Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $56.5B | +$881M | 141 | 1.66% | Increased |
|
| 2 |
BlackRock
New York
| $53.8B | +$641M | 153 | 1.83% | Increased |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $28.9B | +$705M | 111 | 3.02% | Increased |
|
| 4 |
State Street
Boston,
Massachusetts
| $27.4B | +$108M | 143 | 1.74% | Increased |
|
| 5 |
Capital World Investors
Los Angeles,
California
| $16.2B | +$351M | 16 | 3.64% | Increased |
|
| 6 |
T. Rowe Price Associates
Baltimore,
Maryland
| $15.1B | -$11.5B | 88 | 2.48% | Reduced |
|
| 7 |
Morgan Stanley
New York
| $13.8B | +$224M | 164 | 1.88% | Increased |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $13.6B | +$363M | 37 | 2.9% | Increased |
|
| 9 |
Geode Capital Management
Boston,
Massachusetts
| $11.8B | +$248M | 161 | 1.78% | Increased |
|
| 10 |
Massachusetts Financial Services
Boston,
Massachusetts
| $11.1B | -$644M | 23 | 4.15% | Reduced |
|
| 11 |
JP Morgan Chase
New York
| $10.2B | +$155M | 132 | 1.46% | Increased |
|
| 12 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $9.85B | +$11.1B | 21 | 7.87% | New |
|
| 13 |
Bank of America
Charlotte,
North Carolina
| $8.44B | -$230M | 146 | 1.01% | Reduced |
|
| 14 |
Norges Bank
Oslo,
Norway
| $7.63B | +$155M | 49 | 2.03% | Increased |
|
| 15 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $7.29B | -$199M | 31 | 7.51% | Reduced |
|
| 16 |
Northern Trust
Chicago,
Illinois
| $7.21B | -$28M | 135 | 1.65% | Reduced |
|
| 17 |
Capital Research Global Investors
Los Angeles,
California
| $6.88B | +$73.7M | 5 | 2.26% | Increased |
|
| 18 |
Bank of New York Mellon
New York
| $6.52B | -$55.1M | 110 | 1.58% | Reduced |
|
| 19 |
Nuveen
Charlotte,
North Carolina
| $6.51B | +$3.16B | 76 | 2.64% | Increased |
|
| 20 |
Capital International Investors
Los Angeles,
California
| $5.12B | +$156M | 13 | 1.49% | Increased |
|
| 21 |
Franklin Resources
San Mateo,
California
| $5.05B | +$41M | 46 | 2.75% | Increased |
|
| 22 |
Janus Henderson Group
London,
| $4.91B | +$8.68M | 53 | 3.68% | Increased |
|
| 23 |
Goldman Sachs
New York
| $4.58B | +$416M | 120 | 1.16% | Increased |
|
| 24 |
Amundi
Paris,
France
| $4.46B | +$960M | 37 | 2.64% | Increased |
|
| 25 |
Legal & General Group
London,
United Kingdom
| $4.27B | -$160M | 83 | 1.67% | Reduced |
|